Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
Under this two-hit model, Brugge says, one normal copy of BRCA1 ought to be able to carry out DNA repair even when the other ...
The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation ...
HMS alumni Keith Dunleavy, founder and CEO of health care technology company Inovalon, and his wife, Katherine Dunleavy, a ...
Breast cancer rates rose by 1 percent per year from 2012-2021 for all U.S. women combined, with steeper increases for women ...
The results, published Nov. 7 in Current Biology, reveal that some of the stories told for decades about the individuals’ ...
Our educational programs advance Harvard Medical School's core mission to alleviate human suffering by nurturing a diverse group of leaders and future leaders in both clinical care and biomedical ...
For millions of people every year, depression is not just an illness but a grueling pattern: anguish, medications, failure, repeat. Supported by a major grant from the nonprofit Wellcome Leap, two ...
Vivian Kobusingye Birchall, SM, is the host of ActonTV’s Health Care Blind Spots Series, where she interviews stakeholders, physicians, researchers, and industry policymakers on the status of cancer ...
Eight-year-old Emma Broadbent of Dallas, Texas, lives with an ultra-rare disorder that has caused severe delays in brain development, led to hundreds of days in the hospital, and left her functioning ...
Gary Ruvkun, professor of genetics at Harvard Medical School and an investigator at Massachusetts General Hospital, received the 2024 Nobel Prize in Physiology or Medicine for his co-discovery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback